- Home
- CORT vs GTLB Comparison
CORT vs GTLB Comparison
Compare CORT & GTLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CORT
- GTLB
- Stock Information
- Founded
- CORT 1998
- GTLB 2011
- Country
- CORT United States
- GTLB United States
- Employees
- CORT N/A
- GTLB N/A
- Industry
- CORT Biotechnology: Pharmaceutical Preparations
- GTLB EDP Services
- Sector
- CORT Health Care
- GTLB Technology
- Exchange
- CORT Nasdaq
- GTLB Nasdaq
- Market Cap
- CORT 7.5B
- GTLB 7.5B
- IPO Year
- CORT N/A
- GTLB 2021
- Fundamental
- Price
- CORT $71.72
- GTLB $42.03
- Analyst Decision
- CORT Strong Buy
- GTLB Buy
- Analyst Count
- CORT 4
- GTLB 25
- Target Price
- CORT $142.00
- GTLB $64.52
- AVG Volume (30 Days)
- CORT 1.6M
- GTLB 4.9M
- Earning Date
- CORT 07-28-2025
- GTLB 09-02-2025
- Dividend Yield
- CORT N/A
- GTLB N/A
- EPS Growth
- CORT 8.36
- GTLB N/A
- EPS
- CORT 1.14
- GTLB 0.08
- Revenue
- CORT $685,446,000.00
- GTLB $804,571,000.00
- Revenue This Year
- CORT $35.83
- GTLB $26.39
- Revenue Next Year
- CORT $35.24
- GTLB $21.30
- P/E Ratio
- CORT $62.92
- GTLB $523.00
- Revenue Growth
- CORT 30.93
- GTLB 29.31
- 52 Week Low
- CORT $30.77
- GTLB $37.90
- 52 Week High
- CORT $117.33
- GTLB $74.18
- Technical
- Relative Strength Index (RSI)
- CORT 50.50
- GTLB 38.17
- Support Level
- CORT $66.49
- GTLB $45.10
- Resistance Level
- CORT $72.49
- GTLB $47.13
- Average True Range (ATR)
- CORT 2.85
- GTLB 1.74
- MACD
- CORT -0.09
- GTLB 0.13
- Stochastic Oscillator
- CORT 49.95
- GTLB 27.94
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.
About GTLB GitLab Inc.
GitLab Inc operates on an all-remote model. GitLab, a complete DevSecOps platform delivered as a single application. It operates in two competitive landscapes: DevOps point solutions and DevOps platforms. In terms of point solutions that are stitched together, GitLab's offering is substantially different in that it is one platform, one codebase, one interface, and a unified data model that spans the entire DevSecOps lifecycle. DevOps platforms, the principal competitor is Microsoft Corporation following their acquisition of GitHub. GitLab is offered on both self-managed and software-as-a-service (SaaS) models. It is located in the United States, Europe, and Asia Pacific. It focused on accelerating innovation and broadening the distribution of its platform to companies across the world.